James W. Carroll

Jim Carroll
Acting Director of the Office of National Drug Control Policy
Assumed office
February 9, 2018
President Donald Trump
Preceded by Michael Botticelli
White House Principal Deputy Chief of Staff
In office
December 6, 2017 – February 9, 2018
President Donald Trump
Preceded by Kirstjen Nielsen
Succeeded by Zachary Fuentes
Personal details
Political party Republican
Education University of Virginia (BA)
George Mason University (JD)

James W. Carroll Jr. is the current acting director of the U.S. Office of National Drug Control Policy. He was appointed by President Donald Trump on February 9, 2018[1] and then nominated to be the permanent director on April 24, 2018.[2] Earlier, Carroll had served as the White House Deputy Chief of Staff.[3] Prior to that he was General Counsel in the Office of Management and Budget, and an attorney in the Office of the White House Counsel for Presidents Donald Trump and George W. Bush.[4]

External video
White House Opioid Summit, March 1, 2018, CSPAN
National Governors Association, Combating the Opioid Epidemic, July 20, 2018, CSPAN
Fentanyl Safety Training for First Responders, August 30, 2018, CSPAN

References

  1. ↑ "President Donald J. Trump Announces Appointments for the Executive Office of the President". The White House. Retrieved February 9, 2018.
  2. ↑ "PN1864 — James W. Carroll Jr. — Executive Office of the President". U.S. Congress. Retrieved April 26, 2018.
  3. ↑ Restuccia, Andrew; Karni, Annie (December 21, 2017). "Trump eyes former aides as West Wing staffers depart". Politico.
  4. ↑ "President Donald J. Trump Announces Key Additions to the Office of the White House Counsel". The White House. Retrieved March 7, 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.